University of Colorado Denver Eye Hospital
Welcome,         Profile    Billing    Logout  
 3 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Seibold, Leonard K
VENICE, NCT05280366: STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma

Active, not recruiting
N/A
150
US, RoW
Streamline Surgical System, iStent Inject W
New World Medical, Inc.
Open Angle Glaucoma
06/26
06/26
Preston, Mary
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
04/26
04/26
NCT04417530: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Completed
2
22
US
AU-011, Suprachoroidal Microinjector, PDT Laser
Aura Biosciences
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
04/24
04/24
NARROW, NCT05305079: NA-AION Risk Factors: New Perspectives

Completed
N/A
179
Europe, Canada, US, RoW
Rigshospitalet, Denmark, Velux Fonden, Fight for Sight, University of Copenhagen, Hamilton Health Sciences Corporation, Aarhus University Hospital, Aalborg University Hospital, Odense University Hospital, Farabi Eye Hospital, Wellington Hospital, University of Colorado, Denver, University of Utah, Lawson Health Research Institute, University of Sydney, Stanford University, Moorfields Eye Hospital NHS Foundation Trust, Massachusetts Eye and Ear Infirmary, University Hospital, Bordeaux, Synoptik-Fonden
Non-arteritic Ischemic Optic Neuropathy, Optic Disk Drusen
08/24
08/24

Download Options